Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy. 1977

M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg

An unselected material of 83 consecutive and previously untreated adult patients with Hodgkin's disease (HD) from the Stockholm area is presented. The distribution of patients according to age was characteristically bimodal. The histopathological subtypes were 16% lymphocyte predominance (LP), 33% nodular sclerosis (NS), 37% mixed cellularity (MC) and 11% lymphocyte depletion (LD). The patients were treated with aggressive megavoltage irradiation and multidrug chemotherapy. Major factors affecting prognosis were age, clinical stage and constitutional symptoms. Patients with LP and NS subtypes had only slightly better prognosis that patients classified as MC and LD. The overall survival was 68% at 41/2 years, which is close to that reported from other groups with similar composition of their materials with regard to age, histopathology and stage.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
October 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
January 1996, Otolaryngologia polska = The Polish otolaryngology,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
October 1988, European journal of haematology,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
January 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
February 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
January 1985, International journal of radiation oncology, biology, physics,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
May 1977, Cancer,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
April 1982, Cancer treatment reports,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
September 1980, Cancer,
M Björkholm, and G Holm, and H Mellstedt, and B Johansson, and J Askergren, and G Söderberg
July 1998, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!